company background image
4934

Premier Anti-Aging TSE:4934 Stock Report

Last Price

JP¥1.95k

Market Cap

JP¥17.0b

7D

-4.0%

1Y

-86.7%

Updated

26 Jun, 2022

Data

Company Financials +
4934 fundamental analysis
Snowflake Score
Valuation5/6
Future Growth3/6
Past Performance1/6
Financial Health4/6
Dividends0/6

4934 Stock Overview

Premier Anti-Aging Co., Ltd. engages in the planning, development, import/export, mail order, wholesale, and retail business of cosmetics and health foods.

Premier Anti-Aging Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Premier Anti-Aging
Historical stock prices
Current Share PriceJP¥1,947.00
52 Week HighJP¥19,190.00
52 Week LowJP¥1,777.00
Beta0
1 Month Change-48.97%
3 Month Change-43.48%
1 Year Change-86.66%
3 Year Changen/a
5 Year Changen/a
Change since IPO-62.99%

Recent News & Updates

Shareholder Returns

4934JP Personal ProductsJP Market
7D-4.0%7.7%1.9%
1Y-86.7%-25.7%-6.2%

Return vs Industry: 4934 underperformed the JP Personal Products industry which returned -25.7% over the past year.

Return vs Market: 4934 underperformed the JP Market which returned -6.2% over the past year.

Price Volatility

Is 4934's price volatile compared to industry and market?
4934 volatility
4934 Average Weekly Movement12.9%
Personal Products Industry Average Movement4.7%
Market Average Movement4.2%
10% most volatile stocks in JP Market8.5%
10% least volatile stocks in JP Market2.3%

Stable Share Price: 4934 is more volatile than 90% of JP stocks over the past 3 months, typically moving +/- 13% a week.

Volatility Over Time: 4934's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of JP stocks.

About the Company

FoundedEmployeesCEOWebsite
2009152Kiyoshi Matsuurahttps://www.p-antiaging.co.jp

Premier Anti-Aging Co., Ltd. engages in the planning, development, import/export, mail order, wholesale, and retail business of cosmetics and health foods. The company offers its cosmetic products under the DUO and CANADEL brands. It is also involved on the information provision and consulting services related to anti-aging, beauty, and health; research on management and beauty of beauty clinics, etc.; and marketing research and collection and analysis of various information.

Premier Anti-Aging Fundamentals Summary

How do Premier Anti-Aging's earnings and revenue compare to its market cap?
4934 fundamental statistics
Market CapJP¥16.98b
Earnings (TTM)JP¥1.19b
Revenue (TTM)JP¥34.95b

14.3x

P/E Ratio

0.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
4934 income statement (TTM)
RevenueJP¥34.95b
Cost of RevenueJP¥7.09b
Gross ProfitJP¥27.85b
Other ExpensesJP¥26.67b
EarningsJP¥1.19b

Last Reported Earnings

Apr 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)136.23
Gross Margin79.71%
Net Profit Margin3.40%
Debt/Equity Ratio18.8%

How did 4934 perform over the long term?

See historical performance and comparison
We’ve recently updated our valuation analysis.

Valuation

Is 4934 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • PEG Ratio

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 4934?

Other financial metrics that can be useful for relative valuation.

4934 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue0.4x
Enterprise Value/EBITDA3.3x
PEG Ratio1.1x

Price to Earnings Ratio vs Peers

How does 4934's PE Ratio compare to its peers?

4934 PE Ratio vs Peers
The above table shows the PE ratio for 4934 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average18.3x
7823 Artnature
19.2xn/aJP¥23.2b
4936 AXXZIA
24.1x19.8%JP¥24.5b
4932 Almado
20xn/aJP¥11.7b
2927 AFC-HD AMS Life Science
10xn/aJP¥10.7b
4934 Premier Anti-Aging
14.3x12.7%JP¥17.0b

Price-To-Earnings vs Peers: 4934 is good value based on its Price-To-Earnings Ratio (14.3x) compared to the peer average (18.3x).


Price to Earnings Ratio vs Industry

How does 4934's PE Ratio compare vs other companies in the JP Personal Products Industry?

Price-To-Earnings vs Industry: 4934 is good value based on its Price-To-Earnings Ratio (14.3x) compared to the JP Personal Products industry average (21x)


Price to Earnings Ratio vs Fair Ratio

What is 4934's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

4934 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio14.3x
Fair PE Ratio21.5x

Price-To-Earnings vs Fair Ratio: 4934 is good value based on its Price-To-Earnings Ratio (14.3x) compared to the estimated Fair Price-To-Earnings Ratio (21.5x).


Share Price vs Fair Value

What is the Fair Price of 4934 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 4934 (¥1947) is trading below our estimate of fair value (¥3214.78)

Significantly Below Fair Value: 4934 is trading below fair value by more than 20%.


Price to Earnings Growth Ratio

PEG Ratio: 4934 is poor value based on its PEG Ratio (1.1x)


Discover undervalued companies

Future Growth

How is Premier Anti-Aging forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?

Future Growth Score

3/6

Future Growth Score 3/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


12.7%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 4934's forecast earnings growth (12.7% per year) is above the savings rate (0.02%).

Earnings vs Market: 4934's earnings (12.7% per year) are forecast to grow faster than the JP market (9% per year).

High Growth Earnings: 4934's earnings are forecast to grow, but not significantly.

Revenue vs Market: 4934's revenue (5.7% per year) is forecast to grow faster than the JP market (4.4% per year).

High Growth Revenue: 4934's revenue (5.7% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 4934's Return on Equity is forecast to be low in 3 years time (17.6%).


Discover growth companies

Past Performance

How has Premier Anti-Aging performed over the past 5 years?

Past Performance Score

1/6

Past Performance Score 1/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


5.9%

Historical Household annual earnings growth

Earnings and Revenue History

Quality Earnings: 4934 has high quality earnings.

Growing Profit Margin: Insufficient data to determine if 4934's profit margins have improved over the past year.


Past Earnings Growth Analysis

Earnings Trend: Unable to establish if 4934's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.

Accelerating Growth: Unable to compare 4934's past year earnings growth to its 5-year average as it has been trading publicly for less than 3 years.

Earnings vs Industry: Insufficient data to determine if 4934's earnings growth over the past year exceeded the Personal Products industry average.


Return on Equity

High ROE: 4934's Return on Equity (14.6%) is considered low.


Discover strong past performing companies

Financial Health

How is Premier Anti-Aging's financial position?

Financial Health Score

4/6

Financial Health Score 4/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: 4934's short term assets (¥11.9B) exceed its short term liabilities (¥4.2B).

Long Term Liabilities: 4934's short term assets (¥11.9B) exceed its long term liabilities (¥371.0M).


Debt to Equity History and Analysis

Debt Level: 4934 has more cash than its total debt.

Reducing Debt: Insufficient data to determine if 4934's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: 4934's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: 4934's interest payments on its debt are well covered by EBIT (157.8x coverage).


Balance Sheet


Discover healthy companies

Dividend

What is Premier Anti-Aging current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate 4934's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate 4934's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if 4934's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 4934's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as 4934 has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

Kiyoshi Matsuura (53 yo)

no data

Tenure


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Premier Anti-Aging Co., Ltd.'s employee growth, exchange listings and data sources


Key Information

  • Name: Premier Anti-Aging Co., Ltd.
  • Ticker: 4934
  • Exchange: TSE
  • Founded: 2009
  • Industry: Personal Products
  • Sector: Household
  • Implied Market Cap: JP¥16.979b
  • Shares outstanding: 8.72m
  • Website: https://www.p-antiaging.co.jp

Number of Employees


Location

  • Premier Anti-Aging Co., Ltd.
  • Toranomon Hills Mori Tower
  • 8th Floor
  • Tokyo
  • 105-6308
  • Japan

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/06/26 00:00
End of Day Share Price2022/06/24 00:00
Earnings2022/04/30
Annual Earnings2021/07/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.